Chen Q, Miller LJ, and Dong M
Whether it delivers for your individual situation is something only you and your assigned clinical provider can determine
Who should consider standard dosing instead Microdosing isnt the right starting point for everyone: BMI 35+ with significant weight to lose: Standard dosing protocols are backed by robust clinical trial data
ACE2, Metformin, and COVID-19
GLP-1 drugs for heart health Trulicity (dulaglutide) was approved in 2020 for individuals with type 2 diabetes, with or without a history of heart disease, to help reduce the risk of serious cardiovascular events, like heart attacks
Shes a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously